mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Current Biology

• Publication date

  2006-09-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CUB.2006.08.001PMID 16919458
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

  2006cited by this paper
• Activation of Mammalian Target of Rapamycin (mTOR) by Insulin Is Associated with Stimulation of 4EBP1 Binding to Dimeric mTOR Complex 1*

  2006cited by this paper
• Drosophila Target of Rapamycin Kinase Functions as a Multimer

  2006cited by this paper
• Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex

  2005cited by this paper
• Molecular Organization of Target of Rapamycin Complex 2*

  2005cited by this paper
• TOR complex 2 integrates cell movement during chemotaxis and signal relay in Dictyostelium.

  2005cited by this paper
• Mip1, an MEKK2-Interacting Protein, Controls MEKK2 Dimerization and Activation

  2005cited by this paper
• mTOR·RICTOR Is the Ser473 Kinase for Akt/Protein Kinase B in 3T3-L1 Adipocytes*

  2005cited by this paper
• The human stress-activated protein kinase-interacting 1 gene encodes JNK-binding proteins.

  2005cited by this paper
• Growing roles for the mTOR pathway.

  2005cited by this paper
• Alternative polyadenylation and splicing of mRNAs transcribed from the human Sin1 gene.

  2004cited by this paper
• Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control.

  2002influential reference
• A generic protein purification method for protein complex characterization and proteome exploration

  1999cited by this paper
• Sin1: an evolutionarily conserved component of the eukaryotic SAPK pathway

  1999cited by this paper
• Mechanism of activation of protein kinase B by insulin and IGF‐1.

  1996cited by this paper
• Expression of three mammalian cDNAs that interfere with RAS function in Saccharomyces cerevisiae.

  1991cited by this paper

• The mTOR Pathway in Hearing Disorders: Mechanistic Links to Aging, Regeneration, and Neurodegeneration

  2026cites this paper
• Structural basis for a phosphoinositide-driven mTORC2-AKT positive feedback loop

  2026cites this paper
• The mTORC2 component SIN1 post-transcriptionally regulates TYMS levels and modulates P53 activity in response to 5-FU chemotherapy

  2026cites this paper
• Structural and mechanistic basis of mTORC2 activation of protein kinase AKT/PKB.

  2026cites this paper
• Mechanistic Insights into TYSM Protein Regulation by mTORC2 in Response to Chemotherapy

  2025cites this paper
• Novel Role of the Epstein-Barr Virus Encoded Deubiquitinating Enzyme (BPLF1) in mTOR-Mediated Cell Growth and Proliferation Pathways

  2025cites this paper
• Modulation of the tumor microenvironment by the ubiquitin–proteasome system in colorectal cancer

  2025cites this paper
• Role and Mechanisms of the mTOR Signalling Pathway in the Synthesis of Milk Components

  2025cites this paper
• The mTOR Signaling Pathway: Key Regulator and Therapeutic Target for Heart Disease

  2025cites this paper
• The mTOR pathway in Gliomas: From molecular insights to targeted therapies.

  2025cites this paper
• Glycoconjugation of Quinoline as an Effective Strategy for Selective Inhibition of mTORC1.

  2025cites this paper
• Phytochemical modulation of mTOR signaling: emerging nanotechnology-driven therapeutics for rheumatoid arthritis management

  2025cites this paper
• Clear cell renal carcinoma essentially requires CDKL3 for oncogenesis

  2025cites this paper
• A gain-of-function variant in RICTOR predisposes to human obesity.

  2025cites this paper
• Development of a SIN1 targeting inhibitor as a novel therapeutic approach for the treatment of malignancies.

  2025cites this paper
• Liprin-α1 enhances PHLDB3 oncogenic function in colorectal cancer via activation of mTORC2-AKT1 pathway.

  2025cites this paper
• Nutrient Sensing of mTORC1 signaling in cancer and aging.

  2024cites this paper
• mTOR in the Development of Hypoxic Pulmonary Hypertension Associated with Cardiometabolic Risk Factors

  2024cites this paper
• Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment

  2024cites this paper
• The effect of rapamycin treatment on mouse ovarian follicle development in dehydroepiandrosterone-induced polycystic ovary syndrome mouse model.

  2024cites this paper
• Rapamycin improves the survival of epilepsy model cells by blocking phosphorylation of mTOR base on computer simulations and cellular experiments.

  2024cites this paper
• MARCH1 negatively regulates TBK1-mTOR signaling pathway by ubiquitinating TBK1

  2024cites this paper
• Rictor—A Mediator of Progression and Metastasis in Lung Cancer

  2024cites this paper
• The mTORC2 signaling network: targets and cross-talks

  2024cites this paper
• Therapeutic potentials and targeting strategies of quercetin on cancer cells: Challenges and future prospects.

  2024cites this paper
• Metabolic Reprograming of Macrophages: A New Direction in Traditional Chinese Medicine for Treating Liver Failure

  2024cites this paper
• An affinity tool for the isolation of endogenous active mTORC1 from various cellular sources

  2023cites this paper
• Targeting mTOR for Anti-Aging and Anti-Cancer Therapy

  2023cites this paper
• Clinical Implications of mTOR Expression in Papillary Thyroid Cancer—A Systematic Review

  2023cites this paper
• Mechanosensitive mTORC2 independently coordinates leading and trailing edge polarity programs during neutrophil migration

  2023cites this paper
• Safety Evaluations of Rapamycin Perfluorocarbon Nanoparticles in Ovarian Tumor-Bearing Mice

  2023cites this paper
• The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas—New Potential Therapeutic Approach—A Systematic Review

  2023cites this paper
• NMDAR-Arc signaling is required for Memory Updating and is disrupted in Alzheimer's Disease.

  2023cites this paper
• Cellular Metabolism: A Fundamental Component of Degeneration in the Nervous System

  2023cites this paper
• Crosstalk between the mTOR pathway and primary cilia in human diseases.

  2023cites this paper
• MNK, mTOR or eIF4E-selecting the best anti-tumor target for blocking translation initiation.

  2023cites this paper
• Alcohol Dependence Modulates Amygdalar mTORC2 and PKCε Expression in a Rodent Model

  2023cites this paper
• Cognitive Impairment in Multiple Sclerosis

  2023cites this paper
• Rapamycin Perfluorocarbon Nanoparticle Mitigates Cisplatin-Induced Acute Kidney Injury

  2023cites this paper
• mTOR Signaling Pathway and Gut Microbiota in Various Disorders: Mechanisms and Potential Drugs in Pharmacotherapy

  2023cites this paper
• MORG1 limits mTORC1 signaling by inhibiting Rag GTPases.

  2023cites this paper
• Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK)

  2023cites this paper
• Using Drosophila melanogaster to Dissect the Roles of the mTOR Signaling Pathway in Cell Growth

  2023cites this paper
• Promotion of intestinal epithelial cell apoptosis by enterotoxigenic Escherichia coli via PKA-mediated inhibition of mTORC1 activation.

  2023cites this paper
• Ang II Controls the Expression of Mapkap1 by miR-375 and Affects the Function of Islet β Cells

  2023influential citation
• Traditional Chinese medicine for colorectal cancer treatment: potential targets and mechanisms of action

  2023cites this paper
• Paraquat and Parkinson’s Disease: The Molecular Crosstalk of Upstream Signal Transduction Pathways Leading to Apoptosis

  2023cites this paper
• The ATF4-regulated LncRNA MALAT1 promotes odontoblastic differentiation of human dental pulp stem cells via histone demethylase JMJD3: An in vitro study.

  2023cites this paper
• New Insights into the Regulation of mTOR Signaling via Ca2+-Binding Proteins

  2023cites this paper
• TSC2 regulates tumor susceptibility to TRAIL‐mediated T‐cell killing by orchestrating mTOR signaling

  2023cites this paper
• Targeting mTOR Signaling in Type 2 Diabetes Mellitus and Diabetes Complications.

  2022cites this paper
• Structural features of mTORC2 that control substrate-specific activities

  2022cites this paper
• Epstein-Barr Virus LMP1-Activated mTORC1 and mTORC2 Coordinately Promote Nasopharyngeal Cancer Stem Cell Properties

  2022cites this paper
• The ubiquitin ligase Nedd4-2 mediates the regulation of PepT2 by mTORC1 in bovine mammary epithelial cells

  2022cites this paper
• Cell cycle control by the insulin-like growth factor signal: at the crossroad between cell growth and mitotic regulation

  2022cites this paper
• Chiliadenus iphionoides Reduces Body Weight and Improves Parameters Related to Hepatic Lipid and Glucose Metabolism in a High-Fat-Diet-Induced Mice Model of NAFLD

  2022cites this paper
• Cystine induced-mTORC2 activation through promoting Sin1 phosphorylation to suppress cancer cell ferroptosis.

  2022cites this paper
• New mechanistic insights into the RAS-SIN1 interaction at the membrane

  2022cites this paper
• Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1

  2022cites this paper
• mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin

  2022cites this paper
• The Inositol Phosphate System—A Coordinator of Metabolic Adaptability

  2022cites this paper
• In silico comprehensive analysis of coding and non-coding SNPs in human mTOR protein

  2022cites this paper
• Structural insights into Ras regulation by SIN1

  2022cites this paper
• The Translational Regulation in mTOR Pathway

  2022cites this paper
• Effects of heroin self-administration and forced withdrawal on the expression of genes related to the mTOR network in the basolateral complex of the amygdala of male Lewis rats

  2022cites this paper
• Medical Aspects of mTOR Inhibition in Kidney Transplantation

  2022cites this paper
• The central moTOR of metabolism.

  2022cites this paper
• mTORC2 coordinates the leading and trailing edge cytoskeletal programs during neutrophil migration

  2022cites this paper
• Regulation of mTOR complexes in long-lived growth hormone receptor knockout and Snell dwarf mice

  2022cites this paper
• A Comprehensive View on the Quercetin Impact on Colorectal Cancer

  2022cites this paper
• Dysregulation of mTOR Signaling after Brain Ischemia

  2022cites this paper
• Interactions between mTORC2 core subunits Rictor and mSin1 dictate selective and context-dependent phosphorylation of substrate kinases SGK1 and Akt

  2022cites this paper
• Protein kinase C: release from quarantine by mTORC2.

  2022cites this paper
• mTOR pathway: A potential therapeutic target for spinal cord injury.

  2021cites this paper
• EBV LMP1-activated mTORC1 and mTORC2 Coordinately Promote Nasopharyngeal Cancer Stem Cell Formation

  2021cites this paper
• Autophagy and the Lysosomal System in Cancer

  2021cites this paper
• BST2 Suppresses LINE-1 Retrotransposition by Reducing the Promoter Activity of LINE-1 5′ UTR

  2021cites this paper
• Plant TOR signaling network: Complexes, conservations and specificities.

  2021cites this paper
• Translational Aspects of the Mammalian Target of Rapamycin Complexes in Diabetic Nephropathy

  2021cites this paper
• Role of mTor signaling for tubular function and disease.

  2021cites this paper
• Culprits or consequences: Understanding the metabolic dysregulation of muscle in diabetes

  2021cites this paper
• Tyrosine phosphorylation of DEPTOR functions as a molecular switch to activate mTOR signaling

  2021cites this paper
• mTOR Signaling in the Inner Ear as Potential Target to Treat Hearing Loss

  2021cites this paper
• An Immunohistochemical Study of the PTEN/AKT Pathway Involvement in Canine and Feline Mammary Tumors

  2021cites this paper
• Expanding TOR Complex 2 Signaling: Emerging Regulators and New Connections

  2021cites this paper
• Insight into the role of multiple signaling pathways in regulating cancer stem cells of gynecologic cancers.

  2021cites this paper
• PI3K/AKT/MTOR: CONTRIBUTION TO THE TUMOR PHENOTYPE SENSITIVE TO TAMOXIFEN

  2021cites this paper
• Multifaceted control of mRNA translation machinery in cancer.

  2021cites this paper
• RAS interaction with Sin1 is dispensable for mTORC2 assembly and activity

  2021influential citation
• Insulin Resistance and Diabetes Mellitus in Alzheimer’s Disease

  2021cites this paper
• Facile synthesis of rapamycin-peptide conjugates as mTOR and Akt inhibitors.

  2021cites this paper
• Current Approaches and Future Directions for the Treatment of mTORopathies

  2021cites this paper
• mTORC2 controls the activity of PKC and Akt by phosphorylating a conserved TOR interaction motif

  2021cites this paper
• mTOR as a senescence manipulation target: A forked road.

  2021cites this paper
• RNA sensor MDA5 suppresses LINE-1 retrotransposition by regulating the promoter activity of LINE-1 5′-UTR

  2021cites this paper
• Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity

  2021cites this paper
• Novel treatment strategies for neurodegenerative disease with sirtuins

  2021cites this paper
• Signal Transduction of Unique RAS Family Member towards Cell Survival

  2021cites this paper
• mTOR Signaling Pathways

  2021cites this paper
• The complex network of mTOR signaling in the heart.

  2021cites this paper